report by BlackRock
Results for ""
Active/Passive Management
Adding alpha through active management and a consumer sector focus
This piece is approved to use with clients.
Growth in emerging market economies and equity markets continues to be driven by rising levels of income and consumer spending by an expanding middle class.
Policy and Regulatory Commentary
Fed keeps its foot on the gas as the virus threatens the recovery
This piece is approved to use with clients.
Viewpoints from the July 2020 Fed Meeting. The Fed hints at a new policy framework.
Active/Passive Management
Active equity managers may outperform in the coronavirus era
This piece is approved to use with clients.
Equity investors continue to debate the merits of active versus passive management. But rather than frame the discussion in absolute terms, at Nuveen we believe it’s more important to understand how and why different market environments tend to favor either an active or passive approach. The investment landscape in the era of coronavirus invites such an inquiry.
Policy and Regulatory Commentary
Higher Tax Rates Expected in Biden Administration
This piece is approved to use with clients.
A Biden administration is expected to propose higher tax rates to finance various domestic programs.
Policy and Regulatory Commentary
2020 Midyear Market Outlook: Policy, Politics, and Populism
This piece is approved to use with clients.
While the coronavirus crisis dominated the policy agenda in early 2020, investors will need to monitor a host of other risks in the second half.
Policy and Regulatory Commentary
Troubled Small Business Relief Program a Stopgap Measure
This piece is approved to use with clients.
T. Rowe Price expects additional funding for the Paycheck Protection Program to aid small businesses beyond the July 31 expiration date.
Policy and Regulatory Commentary
Consensus Expectations May Be Overestimating the Recovery Trajectory
This piece is approved to use with clients.
T. Rowe Price believes current consensus expectations regarding the coronavirus may be overestimating the trajectory for recovery in the U.S.